Referência de medicamentos
Pasireotide
Pasireotide is a medicine in the class endocrine. It is used for cushing syndrome.
- Classe do medicamento: Endocrine
- Indicado para: cushing syndrome
Última atualização Fontes: US FDA label
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Pontos-chave
- Classe do medicamento
- Endocrine
- Código ATC
- H01CB05
- Formas farmacêuticas comuns
- injeção
- Concentrações comuns
- 20 mg
- Interações conhecidas
- 125 (Contraindicada: 2 · Grave: 44 · Moderada: 78 · Leve: 1)
- Nomes comerciais
- 3
- Países e mercados
- 3
Para que é usado
Como funciona
Injectable cyclohexapeptide somatostatin analogue that binds and activates somatostatin receptors (notably SSTR5, over-expressed in corticotroph tumors), inhibiting ACTH secretion and thereby decreasing cortisol secretion.
Dose habitual em adultos (resumo da bula)
Cushing's disease: initial 0.6 mg or 0.9 mg subcutaneously twice a day; range 0.3 mg to 0.9 mg twice a day; titrate to response and tolerability
Gravidez e amamentação
- Gravidez
- Unknown Limited human data. In rabbits it caused developmental delay at doses below human exposure without maternal toxicity; in rats, malrotated limbs at very high doses. EU label: not recommended in pregnancy; women may become fertile again as cortisol or GH falls, so use contraception.
- Amamentação
- Unknown No human milk data; passes into rat milk. EU label: stop breastfeeding during treatment; US label: weigh benefits. LactMed: a large peptide, likely poorly excreted and digested by the infant, but an alternate drug is preferred.
Efeitos adversos relatados
- Diarrhea
- Nausea
- Hyperglycemia
- Cholelithiasis
- Headache
- Abdominal pain
Contraindicações
- None.
Quem deve ter cuidado
- Hypocortisolism may occur; monitor, and consider dose reduction or interruption and temporary glucocorticoid replacement.
- Hyperglycemia and diabetes: monitor glycemia weekly for first two to three months and after dose increases; optimize antidiabetic therapy before starting.
- Bradycardia and QT prolongation: use caution in at-risk patients; baseline ECG recommended; correct hypokalemia and hypomagnesemia.
Informe ao farmacêutico ou ao médico sobre gravidez ou amamentação, doença renal ou hepática, alergias e todos os outros medicamentos ou suplementos que você usa.
Principais interações (125)
- Dronedarone + Pasireotide Contraindicated
- Pasireotide + Pimozide Contraindicated
- Amiodarone + Pasireotide Major
- Amisulpride + Pasireotide Major
- Amitriptyline + Pasireotide Major
- Anagrelide + Pasireotide Major
- Asenapine + Pasireotide Major
- Azithromycin + Pasireotide Major
- Citalopram + Pasireotide Major
- Clarithromycin + Pasireotide Major
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para abrir a monografia completa de Pasireotide: doses, gravidez e amamentação, efeitos adversos, advertências e todas as interações.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
- IV preparation and dilution
Experimente o Pro+ grátis por 14 dias na web. Sem cartão.
Outros medicamentos desta classe
Perguntas frequentes
What is Pasireotide used for?
Pasireotide is a medicine in the class endocrine. It is used for Cushing syndrome.
What side effects have been reported with Pasireotide?
Diarrhea, Nausea, Hyperglycemia, Cholelithiasis, Headache, Abdominal pain.
Can Pasireotide be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Limited human data. In rabbits it caused developmental delay at doses below human exposure without maternal toxicity; in rats, malrotated limbs at very high doses. EU label: not recommended in pregnancy; women may become fertile again as cortisol or GH falls, so use contraception. Breastfeeding: Unknown. No human milk data; passes into rat milk. EU label: stop breastfeeding during treatment; US label: weigh benefits. LactMed: a large peptide, likely poorly excreted and digested by the infant, but an alternate drug is preferred.
What does Pasireotide interact with?
MediHelp lists 125 known interactions for Pasireotide. Contraindicated: 2 · Major: 44 · Moderate: 78 · Minor: 1. The most serious include Dronedarone, Pimozide, Amiodarone.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
